Chembio Diagnostics, Inc. Gains 39.84%

Wed 01 Apr 20 at 05:30 PM
Chembio Diagnostics, Inc. Gains 39.84%

Chembio Diagnostics, Inc. (CEMI:NASDAQ) jumped higher at $7.16, representing a gain of 39.8%. On Tue 31 Mar 20, CEMI:NASDAQ touched a New 2-Week Intraday High of $5.69. The stock appeared on our News Catalysts scanner on Wed 01 Apr 20 at 04:00 AM in the 'MISCELLANEOUS' category. From Tue 17 Mar 20, the stock recorded 60.00% Up Days and 45.45% Green Days

About Chembio Diagnostics, Inc. (CEMI:NASDAQ)

Chembio Diagnostics Inc develops, manufacture markets & licenses rapid point of care diagnostic tests that detect infectious diseases. Its products are rapid tests for the detection of HIV 1/2 antibodies, & for the detection of HIV & Syphilis antibodies.

Share